Biomarkers and Enzymes for Heart Disease

The term biomarker means "measurable and quantifiable biological parameters (eg, specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) qui serve as clues for health- and physiology-related assessments, Such As disease risk, psychiatric disorders, environmental exposure and Its effects, disease diagnosis, metabolic processes, substance abuse, pregnancy, cell line development, epidemiologic studies, etc.

Biomarkers can indicate indication a variety of health or disease characteristics, including the level or the type of exposure to an environmental factor, genetic susceptibility, genetic responses to exposures, markers of subclinical or clinical disease, or indicators of response to therapy.

  • Troponin test
  • Creatine kinase (CK-MB) test
  • Lactate dehydrogenase(LDH)
  • Aspartate transaminase(AST)
  • Myoglobin (Mb)
  • Ischemia-modified albumin (IMA)
  • Pro-brain natriuretic peptide
  • Glycogen phosphorylase isoenzyme BB

Related Conference of Biomarkers and Enzymes for Heart Disease

May 30-31, 2024

6th Euro Cardiology Congress

Vienna, Austria
May 30-31, 2024

39th World Congress on Heart Diseases

Vienna, Austria
June 20-21, 2024

5th European Summit on Cardiology Research

Dublin, Ireland
July 16-17, 2024

13th World Heart Congress

Paris, France
August 01-02, 2024

38th World Congress on Heart Diseases

Montreal, Canada
September 16-17, 2024

3rd Global Summit on Cardiology and Cardiac Surgery

Paris, France
September 19-20, 2024

7th World Heart and Brain Conference

London, UK
September 19-20, 2024

6th Annual Conference on Vascular Medicine

London, UK
October 17-18, 2024

8th Annual Heart Rhythm Conference

Barcelona, Spain
October 24-25, 2024

11th International Conference on Interventional Cardiology

Zurich, Switzerland

Biomarkers and Enzymes for Heart Disease Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in